Symposium Session: How, when and why to use AI in the clinical management of neovascular AMD: A state-of-the-art by the FRB consortium in Europe

U. Schmidt-Erfurth AUSTRIA 

12:15 Introduction

C. Creuzot-Garcher FRANCE

12:18 Fluid as a biomarker in real-world therapy: A FRB reality check

U. Schmidt-Erfurth AUSTRIA 

12:25 Insights from fluid monitoring in clinical studies

D. Barthelmes SWITZERLAND

12:32 The fluid tool in clinical routine by the European FRB network

G. Reiter AUSTRIA

12:39 Insight from the prospective multi-center clinical trial in AI in AMD: When and what to treat

S. Vujosevic ITALY

12:46 A practical guidance to handle the fluid device

H. Bogunovic AUSTRIA

12:53 Reliability and trustworthiness of automated algorithms

All Faculty

13:00 Discussion